The PxIxIT motif of the RCAN3 inhibits angiogenesis and tumor progression in Triple Negative breast cancer in immunocompetent mice.

Autor: Biçer A; Genes, Disease and Therapy Program, Human Molecular Genetics Group, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain., López-Henares P; Genes, Disease and Therapy Program, Human Molecular Genetics Group, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain., Molero-Magariño M; Genes, Disease and Therapy Program, Human Molecular Genetics Group, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain., Feu-Llauradó A; Bellvitge University Hospital, Pathology Department, L'Hospitalet de Llobregat, Catalunya, Spain., Sabariego-Navarro M; Genes, Disease and Therapy Program, Human Molecular Genetics Group, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain., Bayod S; Health & Biomedicine Department of LEITAT Technological Center, Parc Científic de Barcelona, Baldiri Reixach, Barcelona, Spain., Padilla L; Health & Biomedicine Department of LEITAT Technological Center, Parc Científic de Barcelona, Baldiri Reixach, Barcelona, Spain., Taco MR; Bellvitge University Hospital, Pathology Department, L'Hospitalet de Llobregat, Catalunya, Spain., Larriba S; Genes, Disease and Therapy Program, Human Molecular Genetics Group, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain., Pérez-Riba M; Genes, Disease and Therapy Program, Human Molecular Genetics Group, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain., Serrano-Candelas E; Genes, Disease and Therapy Program, Human Molecular Genetics Group, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.

Publikováno v: Carcinogenesis [Carcinogenesis] 2022 Sep 19; Vol. 43 (8), pp. 808-812.